IRIDEX CORP Files 8-K on Operations and Financials

TL;DR

IRIDEX CORP dropped an 8-K on Jan 14th about their financials. Details TBD.

AI Summary

On January 14, 2025, IRIDEX CORPORATION filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well as financial statements and exhibits. No specific financial figures or operational details were disclosed in the provided text, but the filing indicates a report on these aspects.

Why It Matters

This filing signals that IRIDEX CORPORATION is providing an update on its financial performance and operational status to the public and regulatory bodies.

Risk Assessment

Risk Level: low — The filing is a standard 8-K report for operational and financial updates, not indicating any immediate or specific risks.

Key Players & Entities

• IRIDEX CORPORATION (company) — Registrant
• January 14, 2025 (date) — Date of Report
• 1212 Terra Bella Avenue Mountain View, California 94043 (address) — Principal executive offices

FAQ

Key Financial Figures

• $0.01 — ch Registered Common Stock, par value $0.01 per share IRIX Nasdaq Capital Marke

Filing Documents

• irix-20250114.htm (8-K) — 49KB
• irix-ex99_1.htm (EX-99.1) — 18KB
• img156381773_0.jpg (GRAPHIC) — 14KB
• 0000950170-25-005194.txt ( ) — 206KB
• irix-20250114.xsd (EX-101.SCH) — 29KB
• irix-20250114_htm.xml (XML) — 4KB

02. Results of Operations and Financial Condition

Item 2.02. Results of Operations and Financial Condition. On January 14, 2025, IRIDEX Corporation (the "Company") announced its preliminary, unaudited operational and financial results for its fourth fiscal quarter and full fiscal year ended December 28, 2024. The press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. This information shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release dated January 14, 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). - 2 -

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934,as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. IRIDEX CORPORATION By: /s/ Patrick Mercer Patrick Mercer Chief Executive Officer Date: January 14, 2025 - 3 -

View Full Filing

View this 8-K filing on SEC EDGAR